Updated results of phase 1b study of tarextumab (TRXT, anti-Notch2/3) in combination with etoposide and platinum (EP) in patients (pts) with untreated extensive-stage small-cell lung cancer (ED-SCLC) Meeting Abstract
| Authors: | Chiang, A. C.; Rudin, C. M.; Spira, A. I.; Jotte, R. M.; Gadgeel, S. M.; Mita, A. C.; Hart, L. L.; Gluck, W. L.; Liu, S. V.; Kapoun, A. M.; Xu, L.; Hill, D.; Zhou, L.; Dupont, J.; Spigel, D. R. |
| Abstract Title: | Updated results of phase 1b study of tarextumab (TRXT, anti-Notch2/3) in combination with etoposide and platinum (EP) in patients (pts) with untreated extensive-stage small-cell lung cancer (ED-SCLC) |
| Meeting Title: | 52nd Annual Meeting of the American Society of Clinical Oncology (ASCO) |
| Journal Title: | Journal of Clinical Oncology |
| Volume: | 34 |
| Issue: | 15 Suppl. |
| Meeting Dates: | 2016 Jun 3-7 |
| Meeting Location: | Chicago, IL |
| ISSN: | 0732-183X |
| Publisher: | American Society of Clinical Oncology |
| Date Published: | 2016-05-20 |
| Start Page: | 451s |
| Language: | English |
| ACCESSION: | WOS:000404711506038 |
| DOI: | 10.1200/JCO.2016.34.15_suppl.8564 |
| PROVIDER: | wos |
| Notes: | Meeting Abstract: 8564 -- Source: Wos |
